The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric patients with T-ALL and T-LBL.   Read more: https://www.curetoday.com/view/fda-approves-larger-nelarabine-vial-for-some-leukemias-and-lymphomas